News
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director January 06, 2012 | Press Release
Global Financial Market Turmoil Overshadows Biotech Successes in 2011 January 03, 2012 | Press Release
See all News
Catalyst Biosciences is developing the next generation of biopharmaceuticals by harnessing the catalytic power of proteases. Proteases are naturally occurring protein-degrading enzymes that regulate a wide variety of biological processes. Catalyst is harnessing the power of these enzymes as bio-pharmaceuticals by redirecting them to degrade specific proteins that promote disease.
Website: http://www.catbio.com
